SAB Biotherapeutics, Inc. Common Stock (SABS)

$3.38 +1.81%

EARNINGS ANALYTICS

SAB Biotherapeutics, Inc. Common Stock (SABS) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -9.7% (Nov 22, 2021) and its biggest decline was -20.98% (Mar 31, 2023).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±15.34%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
Mar 31, 2023	☽ POST	$0.57	$0.57	$0.57	0	-20.98%	open_in_new
Nov 22, 2021	☀ PRE	$10.99	$10.99	$10.01	3,960	-9.7%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±15.34%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13G

2 chevron_right

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

3 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G	20260515	open_in_new SEC.gov
SCHEDULE 13G	20260515	open_in_new SEC.gov

Frequently asked about SABS earnings

How much does SABS stock move after earnings? expand_more

Over 2 reports, SABS has moved an average of ±15.34% the session after earnings, closing higher 0.0% of the time.

What was SABS's biggest post-earnings move? expand_more

SABS's largest post-earnings gain on record was -9.7% on Nov 22, 2021, and its largest decline was -20.98% on Mar 31, 2023.

Where can I find SAB Biotherapeutics, Inc. Common Stock's SEC filings? expand_more

All of SAB Biotherapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.